NCT00318344已完成1 期
Evaluation of Atuna Racemosa Toxicity
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 20
- 试验地点
- 2
研究概览
简要总结
For thousands of years people in the South Pacific have used Atuna racemosa extract as a topical anti-inflammatory. We, the researchers at the Mayo Clinic, have shown this extract to also have antibacterial properties. While this extract has been used for decades in the South Pacific, a controlled clinical trial to evaluate toxicity has never been performed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
2 期
Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid TumorsSolid TumorsNCT02045719Faculdade de Medicina do ABC51
已完成
4 期
Efficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in ZanzibarPlasmodium Falciparum MalariaNCT03773536Professor Anders Björkman146
已完成
4 期
ACT MALI: Treatment of Malaria Based on Combination TherapiesMalariaNCT00452907Sanofi780
已完成
1 期
Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)Friedreich AtaxiaNCT04921930Institut National de la Santé Et de la Recherche Médicale, France20
撤回
2 期
Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western CambodiaUncomplicated Falciparum MalariaNCT00936767University of Oxford